Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zoetis (ZTS)
NYSE:ZTS
ZTS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$144.80 - $200.53
Previous CloseN/A
Volume625.10K
Average Volume (3M)3.33M
Market Cap
$70.07B
Enterprise Value$93.65B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)28.6
Beta0.80
Next Earnings
May 01, 2025EPS Estimate
1.41Next Dividend Ex-Date
Apr 21, 2025Dividend Yield1.15%
Share Statistics
EPS (TTM)5.46
Shares Outstanding447,791,930
10 Day Avg. Volume4,538,550
30 Day Avg. Volume3,334,390
Standard Deviation0.07
R-Squared0.43
Alpha-0.00335
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.57
Price to Cash Flow (P/CF)19.40
P/FCF Ratio18.50
Enterprise Value/Market Cap1.34
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit14.33
Enterprise Value/Ebitda23.88
Forecast
1Y Price Target
$207.00Price Target Upside32.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
Bulls Say, Bears Say
Bulls Say
Growth PotentialZoetis is well positioned to drive solid growth from multiple newer product launches globally, particularly in OA and in dermatitis.
Market LeadershipZoetis is viewed as a market leader in an industry with durable secular growth drivers, reinforcing the positive outlook.
Bears Say
Foreign Exchange ImpactForeign exchange headwinds are anticipated to negatively impact Zoetis's revenue and net income in 2025.
---
Ownership Overview
0.07% Insiders
20.21% Mutual Funds
26.35% Other Institutional Investors
31.98% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZTS FAQ
What was Zoetis’s price range in the past 12 months?
Zoetis lowest stock price was $144.80 and its highest was $200.53 in the past 12 months.
What is Zoetis’s market cap?
Zoetis’s market cap is $70.07B.
When is Zoetis’s upcoming earnings report date?
Zoetis’s upcoming earnings report date is May 01, 2025 which is in 69 days.
How were Zoetis’s earnings last quarter?
Zoetis released its earnings results on Feb 13, 2025. The company reported $1.4 earnings per share for the quarter, beating the consensus estimate of $1.362 by $0.038.
Is Zoetis overvalued?
According to Wall Street analysts Zoetis’s price is currently Undervalued.
Does Zoetis pay dividends?
Zoetis pays a Quarterly dividend of $0.5 which represents an annual dividend yield of 1.15%. See more information on Zoetis dividends here
What is Zoetis’s EPS estimate?
Zoetis’s EPS estimate is 1.41.
How many shares outstanding does Zoetis have?
Zoetis has 447,791,930 shares outstanding.
What happened to Zoetis’s price movement after its last earnings report?
Zoetis reported an EPS of $1.4 in its last earnings report, beating expectations of $1.362. Following the earnings report the stock price went down -5.147%.
Which hedge fund is a major shareholder of Zoetis?
Currently, no hedge funds are holding shares in ZTS
---
Zoetis Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$207.00 (32.15% Upside)
$207.00 (32.15% Upside)
Blogger Sentiment
Bullish
ZTS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 502.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $676.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 2.7%
Last 30 Days ▲ 2.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.96%
12-Months-Change
Fundamentals
Return on Equity
50.91%
Trailing 12-Months
Asset Growth
-0.34%
Trailing 12-Months
Company Description
Zoetis
Founded in 1952, New Jersey-based Zoetis, Inc. is the world's largest manufacturer of medicine and vaccinations for pets and livestock in the United States and internationally. Its products are complemented by diagnostic products, genetic tests, bio devices and services.
---
ZTS Company Deck
---
ZTS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Zoetis reported strong financial performance with significant growth in key product segments, particularly in companion animals and dermatology. Despite facing headwinds from foreign exchange and increased competition, the company remains confident in its ability to sustain above-market growth driven by innovation and strategic investments.Read More>---
ZTS Revenue Breakdown
67.83% Companion animal
31.31% Livestock
0.86% Contract manufacturing & human health
---
ZTS Stock 12 Month Forecast
Average Price Target
$207.00
▲(32.15% Upside)
Technical Analysis
Bristol-Myers Squibb
―
Idexx Laboratories
―
Merck & Company
―
Pfizer
―
Elanco Animal Health
―
Best Analysts Covering ZTS
1 Year
1 Year Success Rate
17/23 ratings generated profit
1 Year Average Return
+17.65%
reiterated a buy rating 8 days ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 73.91% of your transactions generating a profit, with an average return of +17.65% per trade.
---